|
C10ORF88 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.25280000104777E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.40150000005335E-06 |
| Normal-vs-Stage2 |
1.618830E-04 |
| Normal-vs-Stage3 |
1.56650000004976E-06 |
| Normal-vs-Stage4 |
2.54030000368388E-08 |
| Stage1-vs-Stage2 |
8.465600E-01 |
| Stage1-vs-Stage3 |
2.669000E-01 |
| Stage1-vs-Stage4 |
1.673520E-02 |
| Stage2-vs-Stage3 |
5.676200E-01 |
| Stage2-vs-Stage4 |
6.514500E-02 |
| Stage3-vs-Stage4 |
1.817440E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.95690000262638E-08 |
| Normal-vs-AfricanAmerican |
2.973700E-02 |
| Normal-vs-Asian |
2.243100E-04 |
| Caucasian-vs-AfricanAmerican |
1.790210E-01 |
| Caucasian-vs-Asian |
5.645000E-01 |
| AfricanAmerican-vs-Asian |
4.099400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.56710000531746E-08 |
| Normal-vs-Female |
5.61619999950302E-07 |
| Male-vs-Female |
1.656640E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.39610000005064E-06 |
| Normal-vs-Age(41-60Yrs) |
1.78079999968439E-07 |
| Normal-vs-Age(61-80Yrs) |
1.6393199999909E-05 |
| Normal-vs-Age(81-100Yrs) |
1.951710E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.415600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.954000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.530800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.519200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.361400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.825200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.385700E-02 |
| Classical-VS-Follicular |
6.946000E-01 |
| Classical-VS-Other |
7.856800E-01 |
| Classical-VS-Normal |
1.007800000008E-06 |
| Tall-VS-Follicular |
9.533900E-02 |
| Tall-VS-Other |
4.013000E-01 |
| Tall-VS-Normal |
2.54749999994974E-06 |
| Follicular-VS-Other |
9.230600E-01 |
| Follicular-VS-Normal |
1.781490E-04 |
| Other-VS-Normal |
5.098000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.12069999958342E-07 |
| Normal-vs-N1 |
1.88407999999196E-05 |
| N0-vs-N1 |
6.810400E-01 |
|
|
